Description
DOPAZIN-MS FORTE — A New-Launch Triple Mechanism Backed by Real Clinical Rationale
DOPAZIN-MS FORTE is an extended-release combination of Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride 1000 mg, formulated for patients with Type 2 Diabetes Mellitus who require comprehensive glycemic management. Dapagliflozin works as an SGLT2 inhibitor that helps eliminate excess glucose through urine, Sitagliptin acts as a DPP-4 inhibitor that raises incretin levels to support glucose-dependent insulin release and Metformin improves insulin sensitivity while lowering hepatic glucose output. This three-way mechanism makes it a genuinely differentiated molecule for franchise partners entering the diabetology space.
Backed by Certified Manufacturing Standards
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company based in Panchkula, Haryana, with production carried out at our Baddi, Himachal Pradesh facility. As a new product launch, DOPAZIN-MS FORTE is manufactured under strict quality protocols so franchise partners can introduce it to doctors and chemists with full confidence in batch consistency and formulation reliability. This is the kind of product-backed credibility that helps a PCD pharma franchise company in India build lasting field relationships rather than one-time orders.
Franchise Highlights for This Product
- Composition: Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin Hydrochloride 1000 mg (ER Tablets)
- Pack Size: 10 X 10 Tablets
- Pack Type: ALU ALU for stability and extended shelf life
- Indication: Type 2 Diabetes Mellitus requiring comprehensive glycemic control
- Category Status: New product launch, ideal for building early market presence
- Suited For: Distributors and medical representatives expanding into diabetology
Franchise partners looking to introduce a genuinely new triple-mechanism molecule to their diabetology basket can explore this and other formulations through our PCD pharma franchise division, along with promotional and launch support for field teams.
Disclaimer: This is a prescription product and should be used strictly under the supervision of a registered medical practitioner.
